Tissue Engineering Stocks List
|2019-10-15||AGE||Calm After Storm||Range Contraction|
|2019-10-15||APOP||Pocket Pivot||Bullish Swing Setup|
|2019-10-15||APOP||Lower Bollinger Band Walk||Weakness|
|2019-10-15||APOP||20 DMA Resistance||Bearish|
|2019-10-15||CLGN||Narrow Range Bar||Range Contraction|
|2019-10-15||CLGN||Bollinger Band Squeeze||Range Contraction|
|2019-10-15||LNDC||New 52 Week Low||Weakness|
|2019-10-15||LNDC||Narrow Range Bar||Range Contraction|
|2019-10-15||LNDC||New 52 Week Closing Low||Bearish|
|2019-10-15||LNDC||Lower Bollinger Band Walk||Weakness|
Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field in its own.
While most definitions of tissue engineering cover a broad range of applications, in practice the term is closely associated with applications that repair or replace portions of or whole tissues (i.e., bone, cartilage, blood vessels, bladder, skin, muscle etc.). Often, the tissues involved require certain mechanical and structural properties for proper functioning. The term has also been applied to efforts to perform specific biochemical functions using cells within an artificially-created support system (e.g. an artificial pancreas, or a bio artificial liver). The term regenerative medicine is often used synonymously with tissue engineering, although those involved in regenerative medicine place more emphasis on the use of stem cells or progenitor cells to produce tissues.